Cargando…

Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico

Latent autoimmune diabetes in adults (LADA) has clinical and metabolic features of type 1 and type 2 diabetes. LADA does not have specific features for its diagnosis apart from autoantibody detection; however, these tests are not affordable in clinical settings. In this cross-sectional study, we ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolasco-Rosales, Germán Alberto, Ramírez-González, Dania, Rodríguez-Sánchez, Ester, Ávila-Fernandez, Ángela, Villar-Juarez, Guillermo Efrén, González-Castro, Thelma Beatriz, Tovilla-Zárate, Carlos Alfonso, Guzmán-Priego, Crystell Guadalupe, Genis-Mendoza, Alma Delia, Ble-Castillo, Jorge Luis, Marín-Medina, Alejandro, Juárez-Rojop, Isela Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148806/
https://www.ncbi.nlm.nih.gov/pubmed/37120620
http://dx.doi.org/10.1038/s41598-023-34171-2
_version_ 1785035050197188608
author Nolasco-Rosales, Germán Alberto
Ramírez-González, Dania
Rodríguez-Sánchez, Ester
Ávila-Fernandez, Ángela
Villar-Juarez, Guillermo Efrén
González-Castro, Thelma Beatriz
Tovilla-Zárate, Carlos Alfonso
Guzmán-Priego, Crystell Guadalupe
Genis-Mendoza, Alma Delia
Ble-Castillo, Jorge Luis
Marín-Medina, Alejandro
Juárez-Rojop, Isela Esther
author_facet Nolasco-Rosales, Germán Alberto
Ramírez-González, Dania
Rodríguez-Sánchez, Ester
Ávila-Fernandez, Ángela
Villar-Juarez, Guillermo Efrén
González-Castro, Thelma Beatriz
Tovilla-Zárate, Carlos Alfonso
Guzmán-Priego, Crystell Guadalupe
Genis-Mendoza, Alma Delia
Ble-Castillo, Jorge Luis
Marín-Medina, Alejandro
Juárez-Rojop, Isela Esther
author_sort Nolasco-Rosales, Germán Alberto
collection PubMed
description Latent autoimmune diabetes in adults (LADA) has clinical and metabolic features of type 1 and type 2 diabetes. LADA does not have specific features for its diagnosis apart from autoantibody detection; however, these tests are not affordable in clinical settings. In this cross-sectional study, we analyzed clinical criteria, metabolic control, pharmacological treatment, and diabetic complications in two groups of patients with diabetes -LADA and T2D- in order to identify specific characteristic of these clinical entities. Finally, we evaluated if the estimated glucose disposal rate (eGDR) and age at diagnosis of diabetes could be used as a diagnostic criterion for LADA. Demographic, biochemical, clinical and treatment were measured in 377 individuals with diabetes. The diagnostics of LADA were determined using Glutamic acid decarboxylase autoantibodies levels. Chi-square test or t-Student test were used to establish differences between groups. To identify factors associated with LADA, a logistic regression analysis was used. Finally, a ROC curve was plotted to assess the possible variables as diagnostic criteria for LADA. The 377 patients with diabetes were separated into 59 patients with LADA and 318 patients with T2D. Patients with LADA showed lower fasting glucose values, fewer diabetic complications, younger age at diagnosis of diabetes, higher insulin use, and higher eGDR in comparison to patients with T2D. Both groups had a mean BMI classified as overweight. The ROC evaluated the sensitivity and specificity, this analysis indicated that an age younger than 40.5 years and an eGDR value higher than 9.75 mg/kg/min correlated better with LADA. These parameters could be useful to identify patients suspected to have LADA at the first level of medical care in the population of southeastern Mexico and refer them to a second level of care.
format Online
Article
Text
id pubmed-10148806
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101488062023-05-01 Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico Nolasco-Rosales, Germán Alberto Ramírez-González, Dania Rodríguez-Sánchez, Ester Ávila-Fernandez, Ángela Villar-Juarez, Guillermo Efrén González-Castro, Thelma Beatriz Tovilla-Zárate, Carlos Alfonso Guzmán-Priego, Crystell Guadalupe Genis-Mendoza, Alma Delia Ble-Castillo, Jorge Luis Marín-Medina, Alejandro Juárez-Rojop, Isela Esther Sci Rep Article Latent autoimmune diabetes in adults (LADA) has clinical and metabolic features of type 1 and type 2 diabetes. LADA does not have specific features for its diagnosis apart from autoantibody detection; however, these tests are not affordable in clinical settings. In this cross-sectional study, we analyzed clinical criteria, metabolic control, pharmacological treatment, and diabetic complications in two groups of patients with diabetes -LADA and T2D- in order to identify specific characteristic of these clinical entities. Finally, we evaluated if the estimated glucose disposal rate (eGDR) and age at diagnosis of diabetes could be used as a diagnostic criterion for LADA. Demographic, biochemical, clinical and treatment were measured in 377 individuals with diabetes. The diagnostics of LADA were determined using Glutamic acid decarboxylase autoantibodies levels. Chi-square test or t-Student test were used to establish differences between groups. To identify factors associated with LADA, a logistic regression analysis was used. Finally, a ROC curve was plotted to assess the possible variables as diagnostic criteria for LADA. The 377 patients with diabetes were separated into 59 patients with LADA and 318 patients with T2D. Patients with LADA showed lower fasting glucose values, fewer diabetic complications, younger age at diagnosis of diabetes, higher insulin use, and higher eGDR in comparison to patients with T2D. Both groups had a mean BMI classified as overweight. The ROC evaluated the sensitivity and specificity, this analysis indicated that an age younger than 40.5 years and an eGDR value higher than 9.75 mg/kg/min correlated better with LADA. These parameters could be useful to identify patients suspected to have LADA at the first level of medical care in the population of southeastern Mexico and refer them to a second level of care. Nature Publishing Group UK 2023-04-29 /pmc/articles/PMC10148806/ /pubmed/37120620 http://dx.doi.org/10.1038/s41598-023-34171-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Nolasco-Rosales, Germán Alberto
Ramírez-González, Dania
Rodríguez-Sánchez, Ester
Ávila-Fernandez, Ángela
Villar-Juarez, Guillermo Efrén
González-Castro, Thelma Beatriz
Tovilla-Zárate, Carlos Alfonso
Guzmán-Priego, Crystell Guadalupe
Genis-Mendoza, Alma Delia
Ble-Castillo, Jorge Luis
Marín-Medina, Alejandro
Juárez-Rojop, Isela Esther
Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title_full Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title_fullStr Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title_full_unstemmed Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title_short Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico
title_sort identification and phenotypic characterization of patients with lada in a population of southeast mexico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148806/
https://www.ncbi.nlm.nih.gov/pubmed/37120620
http://dx.doi.org/10.1038/s41598-023-34171-2
work_keys_str_mv AT nolascorosalesgermanalberto identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT ramirezgonzalezdania identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT rodriguezsanchezester identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT avilafernandezangela identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT villarjuarezguillermoefren identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT gonzalezcastrothelmabeatriz identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT tovillazaratecarlosalfonso identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT guzmanpriegocrystellguadalupe identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT genismendozaalmadelia identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT blecastillojorgeluis identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT marinmedinaalejandro identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico
AT juarezrojopiselaesther identificationandphenotypiccharacterizationofpatientswithladainapopulationofsoutheastmexico